Trial · NCT01831791
Results by group276
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 276
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Any Adverse Events (AEs) and Any Serious Adverse Events (SAEs) | Dutasteride 0.5 mg | Any AE | 64 | Participants | |
| Number of Participants With Any Adverse Events (AEs) and Any Serious Adverse Events (SAEs) | Dutasteride 0.5 mg | Any SAE | 2 | Participants | |
| Number of Participants With Drug-related, Treatment-emergent AEs and AE Leading to Premature Study Drug Discontinuation and Possible Suicidality-related Adverse Event (PSRAE) | Dutasteride 0.5 mg | Any drug related AEs | 20 | Participants | |
| Number of Participants With Drug-related, Treatment-emergent AEs and AE Leading to Premature Study Drug Discontinuation and Possible Suicidality-related Adverse Event (PSRAE) | Dutasteride 0.5 mg | Any treatment-emergent AEs | 64 | Participants | |
| Number of Participants With Drug-related, Treatment-emergent AEs and AE Leading to Premature Study Drug Discontinuation and Possible Suicidality-related Adverse Event (PSRAE) | Dutasteride 0.5 mg | Any AE leading to study drug discontinuation | 0 | Participants | |
| Number of Participants With Drug-related, Treatment-emergent AEs and AE Leading to Premature Study Drug Discontinuation and Possible Suicidality-related Adverse Event (PSRAE) | Dutasteride 0.5 mg | Any PSRAE | 3 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | PBT, Change from N at BL to Y, n=120 | 0 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | PBT, CS, Y (among change from N at BL to Y), n=0 | 0 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | PBT, CS, N (among change from N at BL to Y), n=0 | 0 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | NT, Change from N at BL to Y, n=120 | 1 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | NT, CS, Y (among change from N at BL to Y), n=1 | 1 | Participants | |
| Number of Participants With Change From Baseline in Breast Examination Results Any Time Post-Baseline Visit | Dutasteride 0.5 mg | NT, CS, N (among change from N at BL to Y), n=0 | 0 | Participants | |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Hemoglobin, Week 26, n=114 | 0.61 | Standard Deviation 5.891 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Hemoglobin, Week 52, n=111 | -0.94 | Standard Deviation 5.657 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Hemoglobin, Final value, n=118 | -0.69 | Standard Deviation 5.792 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Albumin, Week 26, n=114 | -0.64 | Standard Deviation 2.014 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Albumin, Week 52, n=111 | -1.42 | Standard Deviation 1.928 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Albumin, Final value, n=118 | -1.31 | Standard Deviation 1.969 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Total protein, Week 26, n=114 | -0.17 | Standard Deviation 3.741 | Grams per liter (g/L) |
| Mean Change From Baseline in Hemoglobin, Albumin and Total Protein at the Indicated Time Points | Dutasteride 0.5 mg | Total protein, Week 52, n=111 | -0.55 | Standard Deviation 3.389 | Grams per liter (g/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01831791/results